Italian Study of Patients With Lymphoma
About this study
It is an observational, non-interventional, prospective, monocentric study, whose objective is to enroll 1500 patients with lymphoma in 5 years within the Institute of Hematology "Seragnoli".
- Condition
- Lymphoma
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Lymphoma
- Age greater than or equal to 18 years at enrollment
- Diagnosis of lymphoma within 3 months of enrollment
- Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment
- Signing of the informed consent form
Where
1 site, 1 recruiting
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy
Contact
-
Pier Luigi Zinzani, MD
+390512143680 pierluigi.zinzani@unibo.it
-
Cinzia Pellegrini, MD
+390512143680 cinzia.pellegrini@aosp.bo.it
Potential match only. Final eligibility is determined by the study team.